If you are a Healthcare Professional and you would like to log in to access this content, please click "Login".
You are now leaving the Lilly Medical Web site
Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Forsteo ® (teriparatide)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information:
Forsteo Summary of Product Characteristics (SmPC)
Forsteo® (teriparatide): Use in Patients with Monoclonal Gammopathy of Undetermined Significance
Patients with MGUS are at risk for progression to multiple myeloma or related malignancies. Patients with skeletal malignancies or bone metastases should be excluded from treatment with Forsteo (contraindication).
Gammopathy of Undetermined Significance
gammopathy of undetermined significance (MGUS) has an approximately
1% per year risk for progression to multiple myeloma or related
patient has MGUS with a likelihood of progression to multiple
myeloma, the clinician may consider not prescribing teriparatide.
factors for a patient with MGUS to progress to multiple myeloma or
related malignancies include
Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain
ratio is an independent risk factor for progression in monoclonal
gammopathy of undetermined significance. Blood.
= bone mineral density
= immunoglobulin A
= immunoglobulin M
= monoclonal gammopathy of undetermined significance
Date of Last Review:March 03, 2020
Was this answer helpful to you?
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at email@example.com